General Catalyst Group Management, LLC
Position in AVBP — ArriVent BioPharma, Inc.
CIK 1637946
Cambridge, MA
Position in AVBP
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$34,484,713
+$4,409,619 QoQ
Shares Held
1,494,786
0.0% QoQ
Ownership
3.21%
of shares outstanding
% of Portfolio
18.79%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in AVBP Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026General Catalyst Group Management, LLC holds $70,872,951 across 4 Biotechnology names. AVBP ranks #1 (48.7% of the industry book) .
All Filings in AVBP
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $34,484,713 | 1,494,786 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $30,075,094 | 1,494,786 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $27,578,801 | 1,494,786 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $32,541,491 | 1,494,786 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $27,638,593 | 1,494,786 | Shares | Defined | 2025-04-16 | |
| 2024-12-31 | $39,821,099 | 1,494,786 | Shares | Defined | 2025-01-23 | |
| 2024-09-30 | $35,127,471 | 1,494,786 | Shares | Defined | 2024-11-06 | |
| 2024-06-30 | $27,728,280 | 1,494,786 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $26,696,877 | 1,494,786 | Shares | Defined | 2024-05-10 | |
| No filing history on record for this holder in this stock. | ||||||